Inflammation in multiple sclerosis

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) that is characterised pathologically by demyelination, gliosis, neuro-axonal damage and inflammation. Despite intense research, the underlying pathomechanisms driving inflammatory demyelination in MS still...

Full description

Saved in:
Bibliographic Details
Published inTherapeutic advances in neurological disorders Vol. 14; p. 17562864211007687
Main Authors Haase, Stefanie, Linker, Ralf A.
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 2021
SAGE PUBLICATIONS, INC
SAGE Publishing
Subjects
Antigens
Autoantigens
Autoimmune Neurology
Central nervous system
Demyelination
Gliosis
Inflammation
Inflammatory diseases
Lymphocytes B
Lymphocytes T
Macrophages
Multiple sclerosis
Myeloid cells
Pathology
Phenotypes
myeloid cells
inflammation
B cells
T cells
immune network
immune regulation
relapsing-remitting multiple sclerosis
Online AccessGet full text

Cover

Abstract Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) that is characterised pathologically by demyelination, gliosis, neuro-axonal damage and inflammation. Despite intense research, the underlying pathomechanisms driving inflammatory demyelination in MS still remain incompletely understood. It is thought to be caused by an autoimmune response towards CNS self-antigens in genetically susceptible individuals, assuming autoreactive T cells as disease-initiating immune cells. Yet, B cells were recognized as crucial immune cells in disease pathology, including antibody-dependent and independent effects. Moreover, myeloid cells are important contributors to MS pathology, and it is becoming increasingly evident that different cell types act in concert during MS immunopathology. This is supported by the finding that the beneficial effects of actual existing disease-modifying therapies cannot be attributed to one single immune cell-type, but rather involve immunological cooperation. The current strategy of MS therapies thus aims to shift the immune cell repertoire from a pro-inflammatory towards an anti-inflammatory phenotype, involving regulatory T and B cells and anti-inflammatory macrophages. Although no existing therapy actually exists that directly induces an enhanced regulatory immune cell pool, numerous studies identified potential net effects on these cell types. This review gives a conceptual overview on T cells, B cells and myeloid cells in the immunopathology of relapsing-remitting MS and discusses potential contributions of actual disease-modifying therapies on these immune cell phenotypes.
AbstractList Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) that is characterised pathologically by demyelination, gliosis, neuro-axonal damage and inflammation. Despite intense research, the underlying pathomechanisms driving inflammatory demyelination in MS still remain incompletely understood. It is thought to be caused by an autoimmune response towards CNS self-antigens in genetically susceptible individuals, assuming autoreactive T cells as disease-initiating immune cells. Yet, B cells were recognized as crucial immune cells in disease pathology, including antibody-dependent and independent effects. Moreover, myeloid cells are important contributors to MS pathology, and it is becoming increasingly evident that different cell types act in concert during MS immunopathology. This is supported by the finding that the beneficial effects of actual existing disease-modifying therapies cannot be attributed to one single immune cell-type, but rather involve immunological cooperation. The current strategy of MS therapies thus aims to shift the immune cell repertoire from a pro-inflammatory towards an anti-inflammatory phenotype, involving regulatory T and B cells and anti-inflammatory macrophages. Although no existing therapy actually exists that directly induces an enhanced regulatory immune cell pool, numerous studies identified potential net effects on these cell types. This review gives a conceptual overview on T cells, B cells and myeloid cells in the immunopathology of relapsing-remitting MS and discusses potential contributions of actual disease-modifying therapies on these immune cell phenotypes.Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) that is characterised pathologically by demyelination, gliosis, neuro-axonal damage and inflammation. Despite intense research, the underlying pathomechanisms driving inflammatory demyelination in MS still remain incompletely understood. It is thought to be caused by an autoimmune response towards CNS self-antigens in genetically susceptible individuals, assuming autoreactive T cells as disease-initiating immune cells. Yet, B cells were recognized as crucial immune cells in disease pathology, including antibody-dependent and independent effects. Moreover, myeloid cells are important contributors to MS pathology, and it is becoming increasingly evident that different cell types act in concert during MS immunopathology. This is supported by the finding that the beneficial effects of actual existing disease-modifying therapies cannot be attributed to one single immune cell-type, but rather involve immunological cooperation. The current strategy of MS therapies thus aims to shift the immune cell repertoire from a pro-inflammatory towards an anti-inflammatory phenotype, involving regulatory T and B cells and anti-inflammatory macrophages. Although no existing therapy actually exists that directly induces an enhanced regulatory immune cell pool, numerous studies identified potential net effects on these cell types. This review gives a conceptual overview on T cells, B cells and myeloid cells in the immunopathology of relapsing-remitting MS and discusses potential contributions of actual disease-modifying therapies on these immune cell phenotypes.
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) that is characterised pathologically by demyelination, gliosis, neuro-axonal damage and inflammation. Despite intense research, the underlying pathomechanisms driving inflammatory demyelination in MS still remain incompletely understood. It is thought to be caused by an autoimmune response towards CNS self-antigens in genetically susceptible individuals, assuming autoreactive T cells as disease-initiating immune cells. Yet, B cells were recognized as crucial immune cells in disease pathology, including antibody-dependent and independent effects. Moreover, myeloid cells are important contributors to MS pathology, and it is becoming increasingly evident that different cell types act in concert during MS immunopathology. This is supported by the finding that the beneficial effects of actual existing disease-modifying therapies cannot be attributed to one single immune cell-type, but rather involve immunological cooperation. The current strategy of MS therapies thus aims to shift the immune cell repertoire from a pro-inflammatory towards an anti-inflammatory phenotype, involving regulatory T and B cells and anti-inflammatory macrophages. Although no existing therapy actually exists that directly induces an enhanced regulatory immune cell pool, numerous studies identified potential net effects on these cell types. This review gives a conceptual overview on T cells, B cells and myeloid cells in the immunopathology of relapsing-remitting MS and discusses potential contributions of actual disease-modifying therapies on these immune cell phenotypes.
Author Linker, Ralf A.
Haase, Stefanie
Author_xml – sequence: 1
  givenname: Stefanie
  surname: Haase
  fullname: Haase, Stefanie
  email: stefanie.haase@ukr.de
  organization: Neuroimmunologie, Klinik und Poliklinik für Neurologie, Universitätsklinik Regensburg, Franz-Josef-Strauss Allee, Regensburg, 93053, Germany
– sequence: 2
  givenname: Ralf A.
  orcidid: 0000-0002-8740-3106
  surname: Linker
  fullname: Linker, Ralf A.
  organization: Department of Neurology, University Hospital Regensburg, Regensburg, Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33948118$$D View this record in MEDLINE/PubMed
BookMark eNp9UU1vEzEUtFARbQM_gAuK4MIlrZ_ttb0XpKriI1IlLuVs-WuDI68d7F0k_n2dppS2CE62nmfmjWdO0VHKySP0GvAZgBDnIDpOJGcEAGPBpXiGTvaz1X549OB-jE5r3WLMiWD4BTqmtGcSQJ6gt-s0RD2Oego5LUNajnOcwi76ZbXRl1xDfYmeDzpW_-ruXKBvnz5eX35ZXX39vL68uFrZjpJpRR1oSowlzPXUDth3A_XeWBgEFoICdl3PhHNgmCDaSO6FGTBQYRk4zBldoPVB12W9VbsSRl1-qayDuh3kslG6TKHZUkY7A5ha7KRhWjBtmAFDNO-c4X3btkAfDlq72YzeWZ-mouMj0ccvKXxXm_xTSdxRSUkTeH8nUPKP2ddJjaFaH6NOPs9VkY4Q2hMhaYO-ewLd5rmkFpUiHChhLXPeUG8eOrq38ruKBoADwLbUa_HDPQSw2tet_qq7ccQTjg3TbZXtUyH-l3l2YFa98X8M_5twA5DLuP4
CitedBy_id crossref_primary_10_1007_s00415_025_12917_4
crossref_primary_10_53446_actamednicomedia_1306052
crossref_primary_10_3390_ijms231710136
crossref_primary_10_1038_s41598_023_30237_3
crossref_primary_10_3390_ijms251910502
crossref_primary_10_1007_s11064_023_03981_1
crossref_primary_10_1016_j_nrl_2023_04_008
crossref_primary_10_3390_life12071094
crossref_primary_10_1016_j_bbagen_2023_130395
crossref_primary_10_1007_s11033_023_08812_8
crossref_primary_10_1093_ije_dyac039
crossref_primary_10_3389_fneur_2022_835162
crossref_primary_10_1021_acsami_2c17631
crossref_primary_10_23736_S1825_859X_24_00252_4
crossref_primary_10_3390_ijms23126788
crossref_primary_10_3390_ijms25084431
crossref_primary_10_1039_D1MD00374G
crossref_primary_10_3390_cells13161316
crossref_primary_10_2147_JIR_S382827
crossref_primary_10_1097_MS9_0000000000002967
crossref_primary_10_1016_j_jns_2021_118072
crossref_primary_10_1016_j_neuroscience_2024_04_004
crossref_primary_10_3389_fnins_2022_901360
crossref_primary_10_1080_1028415X_2024_2425649
crossref_primary_10_17343_sdutfd_1330810
crossref_primary_10_1016_j_biopha_2024_116297
crossref_primary_10_3389_fphys_2021_770820
crossref_primary_10_1038_s41467_024_45746_6
crossref_primary_10_3390_cells13110891
crossref_primary_10_3390_cimb45100489
crossref_primary_10_3390_ijms25137372
crossref_primary_10_3390_biomedicines9080943
crossref_primary_10_1002_wrna_1772
crossref_primary_10_3390_neurolint16060127
crossref_primary_10_1007_s00115_021_01176_z
crossref_primary_10_3389_fneur_2024_1482096
crossref_primary_10_1186_s12974_022_02582_z
crossref_primary_10_4103_ed_ed_16_24
crossref_primary_10_1073_pnas_2117034119
crossref_primary_10_3390_jcm13175056
crossref_primary_10_1007_s12031_024_02301_8
crossref_primary_10_3174_ajnr_A8060
crossref_primary_10_1007_s12035_022_03187_6
crossref_primary_10_1016_j_msard_2023_104914
crossref_primary_10_3390_ijms231911532
crossref_primary_10_1186_s12951_024_02681_4
crossref_primary_10_1097_MS9_0000000000002231
crossref_primary_10_3390_neurosci4030019
crossref_primary_10_1016_j_heliyon_2023_e21741
crossref_primary_10_1039_D3MA00736G
crossref_primary_10_1097_MD_0000000000037297
crossref_primary_10_3390_cells12141872
crossref_primary_10_3390_nu15040942
crossref_primary_10_3390_sclerosis1020011
crossref_primary_10_1016_j_heliyon_2024_e41166
crossref_primary_10_56543_aaeeu_2022_1_2_08
crossref_primary_10_4103_ejpi_EJPI_D_24_00043
crossref_primary_10_1016_j_msard_2025_106268
crossref_primary_10_2478_auoc_2022_0024
crossref_primary_10_3390_diagnostics14171993
crossref_primary_10_1016_j_brainresbull_2024_110885
crossref_primary_10_1007_s10753_024_02079_2
crossref_primary_10_3390_ijms241612631
crossref_primary_10_3390_jcm14020373
crossref_primary_10_3390_ijms26010032
crossref_primary_10_1080_08820139_2023_2173078
crossref_primary_10_1038_s41434_025_00518_9
crossref_primary_10_3233_JAD_240088
crossref_primary_10_3389_fimmu_2022_912005
crossref_primary_10_3390_biomedicines12071580
crossref_primary_10_7759_cureus_71458
crossref_primary_10_1007_s42535_023_00753_8
crossref_primary_10_1186_s12950_025_00439_9
crossref_primary_10_1016_j_jns_2023_122827
crossref_primary_10_1080_1744666X_2022_2117160
crossref_primary_10_1007_s00005_021_00628_3
crossref_primary_10_5937_jomb0_45083
Cites_doi 10.1126/science.1086907
10.1177/1352458513483889
10.1016/S1474-4422(10)70086-7
10.1002/ana.21363
10.1056/NEJMoa0706383
10.1111/j.1749-6632.2011.06347.x
10.1002/ana.410190610
10.1038/nn.3469
10.1038/icb.2014.15
10.1007/BF02150231
10.1126/science.1142883
10.1172/JCI63681
10.1177/1352458515574895
10.4049/jimmunol.178.10.6092
10.1016/j.clim.2014.02.001
10.1093/brain/awx113
10.4049/jimmunol.170.4.2153
10.1172/JCI22833
10.1186/s12974-018-1334-y
10.4049/jimmunol.1400118
10.4049/jimmunol.1103354
10.1007/s11481-010-9201-3
10.1016/j.jaut.2017.07.007
10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q
10.1172/JCI68775
10.1002/ana.22230
10.1182/blood-2009-07-235028
10.3389/fimmu.2017.00753
10.4049/jimmunol.1601572
10.1084/jem.192.6.899
10.1002/acn3.270
10.1038/s41586-018-0119-x
10.1007/s12035-016-0245-0
10.1016/j.jaut.2017.10.011
10.1177/1756286418819074
10.1038/nrneurol.2013.95
10.1084/jem.20031579
10.1002/1097-4547(20010201)63:3<290::AID-JNR1023>3.0.CO;2-4
10.1002/ana.21939
10.4049/jimmunol.1402029
10.1001/jamaneurol.2014.1472
10.4049/jimmunol.1302884
10.1016/j.jaut.2016.03.012
10.1093/brain/awm038
10.1212/WNL.37.7.1097
10.1038/nrn3275
10.4049/jimmunol.1301284
10.1002/ana.21438
10.1016/j.msard.2021.102802
10.1093/brain/awh707
10.1056/NEJMoa073493
10.4049/jimmunol.156.1.5
10.1038/5532
10.1016/0008-8749(89)90117-2
10.3389/fimmu.2020.00594
10.1016/j.cell.2018.11.035
10.1126/science.aan4183
10.1016/S0165-5728(96)00101-4
10.1016/S0165-5728(01)00371-X
10.1177/135245859900500206
10.4049/jimmunol.1501960
10.3390/cells8010012
10.1016/j.cell.2020.02.035
10.3390/nu12072097
10.1016/j.immuni.2007.12.004
10.1038/nm1564
10.1016/j.cell.2013.03.010
10.1016/j.expneurol.2014.03.009
10.1097/00000441-195001000-00009
10.1212/NXI.0000000000000157
10.1002/ana.21141
10.1111/imr.12169
10.1016/j.jneuroim.2011.08.002
10.1038/nri3700
10.1002/art.24998
10.1093/brain/awy301
10.1016/j.jneuroim.2004.07.019
10.1016/j.jneuroim.2017.05.004
10.1126/scitranslmed.aab4176
10.1093/brain/awr182
10.1093/brain/awl075
10.1002/ana.20016
10.1016/S0140-6736(08)61620-7
10.1038/s41467-019-13731-z
10.1073/pnas.1915309116
10.1177/1352458515601513
10.1084/jem.20111675
10.4049/jimmunol.169.9.4712
10.4049/jimmunol.172.6.3893
10.1038/415536a
10.1007/s12026-012-8297-3
10.1016/S0361-9230(03)00095-9
10.1371/journal.pone.0175538
10.1111/j.1750-3639.2004.tb00049.x
10.1016/j.jneuroim.2012.02.015
10.1038/ni833
10.1007/s00415-013-7145-2
10.1073/pnas.0812183106
10.2353/ajpath.2008.070690
10.1002/ana.21800
10.1111/j.1600-0404.1983.tb04841.x
10.1016/S0140-6736(11)61649-8
10.1016/j.it.2003.09.005
10.1016/j.jneuroim.2011.06.006
10.1182/blood-2002-04-1164
10.1006/dbio.1999.9466
10.1016/S0002-9343(48)90389-1
10.1016/j.cell.2018.08.011
10.1186/1742-2094-10-35
10.3389/fimmu.2018.03116
10.1177/1352458517740213
10.1038/nature10251
10.1212/WNL.0000000000010909
10.1073/pnas.1522730113
10.3389/fimmu.2013.00023
10.4049/jimmunol.172.11.7144
10.4172/2155-9899.1000143
10.1212/NXI.0000000000000183
10.1172/JCI119455
10.4049/jimmunol.0804247
10.1002/ana.21748
10.1002/ana.24190
10.1111/imcb.1025
10.1038/ni1309
10.1016/j.immuni.2011.02.006
10.1038/nm0502-500
10.1002/eji.200526065
10.1007/s00401-013-1082-0
10.1084/jem.20031819
10.1016/0165-5728(83)90036-X
10.1084/jem.192.7.1075
10.3390/ijms21218217
10.1084/jem.177.1.57
10.1038/nm.2389
10.1016/j.immuni.2015.09.007
10.1016/0165-5728(91)90014-X
10.1016/S0165-5728(98)00145-3
10.2147/tcrm.2007.3.2.259
10.1016/S0165-5728(00)00396-9
10.1016/j.immuni.2018.10.005
10.1371/journal.pone.0051867
10.4049/jimmunol.1302519
10.1084/jem.20041257
10.1126/scitranslmed.aaa8038
10.1007/s11481-010-9248-1
10.1172/JCI0215751
10.1126/sciimmunol.abc7191
10.1002/ana.21652
10.1016/j.intimp.2009.03.004
10.1016/j.jneuroim.2011.10.014
10.1111/j.1600-065X.1996.tb00921.x
10.1093/brain/awp289
10.1016/j.jns.2008.12.029
10.1073/pnas.2012249117
10.1056/NEJMoa1601277
10.1038/nature11501
10.1056/NEJMoa1110740
10.1073/pnas.0502187102
10.1038/ni1261
10.1177/1352458510386996
ContentType Journal Article
Copyright The Author(s), 2021
The Author(s), 2021.
The Author(s), 2021. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s), 2021 2021 SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
Copyright_xml – notice: The Author(s), 2021
– notice: The Author(s), 2021.
– notice: The Author(s), 2021. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s), 2021 2021 SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
DBID AFRWT
AAYXX
CITATION
NPM
3V.
7TK
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
7X8
5PM
DOA
DOI 10.1177/17562864211007687
DatabaseName Sage Journals GOLD Open Access 2024
CrossRef
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Psychology
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
CrossRef


Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: AFRWT
  name: Sage Journals GOLD Open Access 2024
  url: http://journals.sagepub.com/
  sourceTypes: Publisher
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1756-2864
ExternalDocumentID oai_doaj_org_article_badb103c0d8b4a74ab4b1b2a65db6977
PMC8053832
33948118
10_1177_17562864211007687
10.1177_17562864211007687
Genre Journal Article
Review
GroupedDBID ---
-TM
01A
0R~
123
18M
29Q
4.4
53G
54M
5VS
7X7
8FI
8FJ
AABMB
AADUE
AAKDD
AAQDB
AARDL
AARIX
AASGM
ABAWP
ABEIX
ABFWQ
ABJIS
ABKRH
ABNCE
ABQXT
ABRHV
ABUWG
ABVFX
ACARO
ACDSZ
ACDXX
ACGFS
ACOFE
ACROE
ACRPL
ADBBV
ADEBD
ADNMO
ADOGD
ADYCS
ADZZY
AENEX
AEQLS
AERKM
AEUHG
AEWDL
AEXNY
AFCOW
AFEET
AFKRA
AFKRG
AFRWT
AFUIA
AFWMB
AGNHF
AGQPQ
AHHFK
AJUZI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ARTOV
ASPBG
AUTPY
AUVAJ
AVWKF
AYAKG
AZFZN
B8M
BAWUL
BCNDV
BDDNI
BENPR
BKSCU
BPHCQ
BSEHC
BVXVI
CAG
CCPQU
CDWPY
CFDXU
COF
CS3
DC-
DC.
DIK
DOPDO
E3Z
EBS
EJD
EMOBN
F5P
FEDTE
FYUFA
GROUPED_DOAJ
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
GX1
H13
HMCUK
HVGLF
HYE
HZ~
J8X
K.F
N9A
O9-
OK1
P.B
PHGZM
PHGZT
PIMPY
PQQKQ
PSYQQ
ROL
RPM
S01
SAUOL
SCDPB
SCNPE
SFC
UKHRP
ZONMY
ZPPRI
ZRKOI
ZSSAH
AAYXX
ACHEB
CITATION
M4V
NPM
3V.
7TK
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c532t-3d1a32bc24d93cf0e5f3eebc1f7077310d5947dd1b472ab86e7bf0137c41d0643
IEDL.DBID DOA
ISSN 1756-2864
1756-2856
IngestDate Wed Aug 27 01:32:10 EDT 2025
Thu Aug 21 13:32:20 EDT 2025
Fri Jul 11 09:41:33 EDT 2025
Mon Jun 30 11:56:12 EDT 2025
Thu Apr 03 07:02:20 EDT 2025
Tue Jul 01 05:28:11 EDT 2025
Thu Apr 24 23:00:49 EDT 2025
Tue Jun 17 22:26:18 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords myeloid cells
inflammation
B cells
T cells
immune network
immune regulation
relapsing-remitting multiple sclerosis
Language English
License This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
The Author(s), 2021.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c532t-3d1a32bc24d93cf0e5f3eebc1f7077310d5947dd1b472ab86e7bf0137c41d0643
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-8740-3106
OpenAccessLink https://doaj.org/article/badb103c0d8b4a74ab4b1b2a65db6977
PMID 33948118
PQID 2613247406
PQPubID 4450847
ParticipantIDs doaj_primary_oai_doaj_org_article_badb103c0d8b4a74ab4b1b2a65db6977
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8053832
proquest_miscellaneous_2522392783
proquest_journals_2613247406
pubmed_primary_33948118
crossref_primary_10_1177_17562864211007687
crossref_citationtrail_10_1177_17562864211007687
sage_journals_10_1177_17562864211007687
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-00-00
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – year: 2021
  text: 2021-00-00
PublicationDecade 2020
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: England
– name: London
– name: Sage UK: London, England
PublicationTitle Therapeutic advances in neurological disorders
PublicationTitleAlternate Ther Adv Neurol Disord
PublicationYear 2021
Publisher SAGE Publications
SAGE PUBLICATIONS, INC
SAGE Publishing
Publisher_xml – name: SAGE Publications
– name: SAGE PUBLICATIONS, INC
– name: SAGE Publishing
References Makhlouf, Weiner, Khoury 2001; 119
Monney, Sabatos, Gaglia 2002; 415
Kabat, Freedman 1950; 219
Ferber, Brocke, Taylor-Edwards 1996; 156
Kebir, Ifergan, Alvarez 2009; 66
Pul, Morbiducci, Škuljec 2012; 7
Lisak, Nedelkoska, Benjamins 2017; 309
Fife, Huffnagle, Kuziel 2000; 192
Viglietta, Baecher-Allan, Weiner 2004; 199
Nicoletti, Patti, Cocuzza 1996; 70
Ray, Basu, Williams 2012; 188
Pender 2003; 24
Lock, Hermans, Pedotti 2002; 8
Auffray, Fogg, Garfa 2007; 317
Xiao, Linington, Link 1991; 31
Gran, Chu, Zhang 2004; 156
Kouwenhoven, Teleshova, Özenci 2001; 112
Hellings, Barée, Verhoeven 2001; 63
Wilk, Witte, Marquardt 2009; 60
Monaco, Nicholas, Reynolds
Waldburger, Hastings, Schaub 1996; 148
Michell-Robinson, Moore, Healy 2016; 3
Srivastava, Aslam, Kalluri 2012; 367
Ascherio, Munger, Simon 2010; 9
Izikson, Klein, Charo 2000; 192
Guarda, Braun, Staehli 2011; 34
Blumenfeld, Staun-Ram, Miller 2016; 70
Mirandola, Hallal, Farias 2009; 9
Miron, Boyd, Zhao 2013; 16
Han, Lin, Wu 2014; 192
Rojas, Pröbstel, Porfilio 2019; 176
Ireland, Guzman, O’Brien 2014; 71
Dominguez-Villar, Baecher-Allan, Hafler 2011; 17
Siritho, Freedman 2009; 279
Zhang, Zhang, Schittenhelm 2011; 237
Bar-Or, Calabresi, Arnold 2008; 63
Gingele, Jacobus, Konen
Kohm, Carpentier, Anger 2002; 169
Wiendl, Gross 2013; 9
Villar, Casanova, Ouamara 2014; 76
Miyazaki, Niino, Fukazawa 2014; 151
Wu, Rauch, Korpos 2009; 182
Boven, Van Meurs, Van Zwam 2006; 129
Magliozzi, Howell, Vora 2007; 130
Hutchinson 2007; 3
Panitch, Hirsch, Schindler 1987; 37
Navas-Madroñal, Valero-Mut, Martínez-Zapata 2017; 12
Meffre 2011; 1246
Ziegler-Heitbrock, Hofer
Pul, Moharregh-Khiabani, Škuljec 2011; 6
Kabat, Glusman, Knaub 1948; 4
Wardemann, Yurasov, Schaefer 2003; 301
Stys, Zamponi, van Minnen 2012; 13
Barr, Shen, Brown 2012; 209
Bielekova, Sung, Kadom 2004; 172
Moccia, Capacchione, Lanzillo 2019; 12
Ingersoll, Spanbroek, Lottaz 2010; 115
Sie, Korn, Mitsdoerffer 2014; 262
Capasso, Nozzolillo, Scalia 2021; 49
Cao, Goods, Raddassi 2015; 7
Hauser, Waubant, Arnold 2008; 358
Haschka, Tymoszuk, Bsteh
Henderson, Barnett, Parratt 2009; 66
Genain, Cannella, Hauser 1999; 5
Korn, Reddy, Gao 2007; 13
Magliozzi, Howell, Reeves 2010; 68
Ascherio, Munger 2010; 5
Durelli, Conti, Clerico 2009; 65
Kim, Ifergan, Antel 2004; 172
Langrish, Chen, Blumenschein 2005; 201
Munger, Bentzen, Laursen 2013; 19
Perry 1998; 90
Burger, Molnarfi, Weber 2009; 106
Yoshizaki, Miyagaki, DiLillo 2012; 491
Wajgt, Górny 1983; 68
Plemel, Juzwik, Benson 2015; 21
Di Dario, Colombo, Govi 2015; 2
Moccia, van de Pavert, Eshaghi 2020; 95
Lucchinetti, Brück, Parisi 2000; 47
Brucklacher-Waldert, Stuerner, Kolster 2009; 132
Kinnunen, Chamberlain, Morbach 2013; 123
Carlin, Stamatiades, Auffray 2013; 153
Barnett, Prineas 2004; 55
Hauser, Bar-Or, Comi 2017; 376
Hafler, Compston 2007; 357
Charoenngam, Holick
Zrzavy, Hametner, Wimmer 2017; 140
Duscha, Gisevius, Hirschberg
Park, Li, Yang 2005; 6
Singh, Metz, Amor 2013; 125
Chen, Chen, Deng 2012; 242
Gross, Schulte-Mecklenbeck, Klinsing
Bettelli, Sullivan, Szabo 2004; 200
Arellano, Acuña, Reyes 2017; 8
Grewal, Flavell 1996; 153
Kim, Kim, Shin 2018; 15
Kornek, Lassmann 2003; 61
Vogel, Vereyken, Glim 2013; 10
Tzartos, Friese, Craner 2008; 172
Brändle, Obermeier, Senel 2016; 113
Duddy, Niino, Adatia 2007; 178
Traugott, Reinherz, Raine 1983; 4
Ando, Clayton, Kono 1989; 124
Palanichamy, Jahn, Nickles 2014; 193
Nissimov, Hajiyeva, Torke 2020; 117
Kowarik, Grummel, Wemlinger 2014; 261
Robinson, Miller 1999; 216
Sawcer, Hellenthal, Pirinen 2011; 476
Kleinewietfeld, Hafler 2014; 259
Lisak, Benjamins, Nedelkoska 2012; 246
Zhang, Gran, Yu 2003; 170
Delneste, Charbonnier, Herbault 2003; 101
Barnett, Simkins, Barnett 2014; 192
von Essen, Ammitzbøll, Hansen 2019; 142
Shlomchik 2008; 28
Guilliams, Mildner, Yona 2018; 49
Mazzola, Raheja, Regev 2019; 25
Villar, Sádaba, Roldán 2005; 115
Ascherio, Munger 2007; 61
Wong, Yeap, Tai 2012; 53
Matusevicius, Kivisäkk, He 1999; 5
Bar-Or, Fawaz, Fan 2010; 67
Li, Rezk, Li 2017; 198
Hauser, Bhan, Gilles 1986; 19
Kappos, Li, Calabresi 2011; 378
Chuluundorj, Harding, Abernethy 2014; 92
Becher, Durell, Noelle 2002; 110
Gjelstrup, Stilund, Petersen 2018; 96
Genç, Dona, Reder 1997; 99
Lückel, Picard, Raifer 2019; 10
Huber, Heink, Pagenstecher
Colotta, Jansson, Bonelli 2017; 85
Jelcic, Al Nimer, Wang 2018; 175
Walters, Webster, Daley 2014; 193
Cantuti-Castelvetri, Fitzner, Bosch-Queralt 2018; 359
Hikawa, Takenaka 1996; 16
Pröbstel, Zhou, Baumann
Serafini, Rosicarelli, Magliozzi 2004; 14
Gold, Linington, Lassmann 2006; 129
Haghikia, Jörg, Duscha 2015; 43
Okada, Ochi, Fujii 2018; 88
Waschbisch, Schröder, Schraudner 2016; 196
Correale, Farez, Razzitte 2008; 64
Bodhankar, Galipeau, Vandenbark 2013; 4
Rothhammer, Borucki, Tjon 2018; 557
Haas, Hug, Viehöver 2005; 35
Sabatino, Wilson, Calabresi 2019; 116
Howell, Reeves, Nicholas 2011; 134
Fillatreau, Sweenie, McGeachy 2002; 3
Serbina, Pamer 2006; 7
Compston, Coles 2008; 372
Lassmann 2018; 9
Hong, Li, Zhang 2005; 102
Baron, Madri, Ruddle 1993; 177
Sola, Mandrioli, Simone 2011; 17
Schubert, Hu, Kumar 2015; 194
Du, Zhang, Chen 2017; 54
Luessi, Kraus, Trinschek 2015; 21
Pitzalis, Jones, Bombardieri 2014; 14
Brennan, Galban-Horcajo, Rinaldi 2011; 238
Li, Rezk, Miyazaki 2015; 7
bibr119-17562864211007687
bibr106-17562864211007687
bibr91-17562864211007687
bibr10-17562864211007687
bibr89-17562864211007687
bibr63-17562864211007687
bibr134-17562864211007687
bibr50-17562864211007687
bibr147-17562864211007687
bibr49-17562864211007687
bibr76-17562864211007687
bibr121-17562864211007687
bibr23-17562864211007687
bibr90-17562864211007687
bibr107-17562864211007687
bibr161-17562864211007687
bibr36-17562864211007687
bibr1-17562864211007687
bibr148-17562864211007687
bibr62-17562864211007687
bibr88-17562864211007687
bibr122-17562864211007687
bibr92-17562864211007687
bibr132-17562864211007687
bibr118-17562864211007687
bibr37-17562864211007687
bibr47-17562864211007687
bibr52-17562864211007687
bibr22-17562864211007687
bibr158-17562864211007687
bibr12-17562864211007687
bibr77-17562864211007687
bibr133-17562864211007687
bibr61-17562864211007687
bibr108-17562864211007687
bibr159-17562864211007687
bibr38-17562864211007687
bibr51-17562864211007687
bibr149-17562864211007687
bibr48-17562864211007687
bibr11-17562864211007687
bibr21-17562864211007687
bibr78-17562864211007687
bibr20-17562864211007687
bibr151-17562864211007687
bibr109-17562864211007687
bibr129-17562864211007687
bibr18-17562864211007687
bibr116-17562864211007687
bibr2-17562864211007687
bibr87-17562864211007687
bibr93-17562864211007687
Waldburger KE (bibr24-17562864211007687) 1996; 148
bibr104-17562864211007687
bibr40-17562864211007687
bibr111-17562864211007687
bibr13-17562864211007687
bibr131-17562864211007687
bibr60-17562864211007687
bibr124-17562864211007687
bibr73-17562864211007687
bibr9-17562864211007687
bibr53-17562864211007687
bibr80-17562864211007687
bibr144-17562864211007687
bibr85-17562864211007687
bibr4-17562864211007687
bibr95-17562864211007687
bibr65-17562864211007687
bibr75-17562864211007687
bibr55-17562864211007687
bibr156-17562864211007687
bibr35-17562864211007687
bibr25-17562864211007687
bibr45-17562864211007687
bibr136-17562864211007687
bibr146-17562864211007687
bibr69-17562864211007687
bibr56-17562864211007687
bibr141-17562864211007687
bibr30-17562864211007687
bibr139-17562864211007687
bibr71-17562864211007687
bibr126-17562864211007687
bibr84-17562864211007687
bibr113-17562864211007687
bibr15-17562864211007687
bibr5-17562864211007687
bibr97-17562864211007687
bibr100-17562864211007687
bibr6-17562864211007687
bibr114-17562864211007687
bibr96-17562864211007687
bibr101-17562864211007687
bibr29-17562864211007687
bibr16-17562864211007687
bibr83-17562864211007687
bibr43-17562864211007687
bibr70-17562864211007687
bibr154-17562864211007687
bibr127-17562864211007687
bibr17-17562864211007687
bibr72-17562864211007687
bibr112-17562864211007687
bibr27-17562864211007687
bibr98-17562864211007687
bibr138-17562864211007687
bibr82-17562864211007687
bibr102-17562864211007687
bibr7-17562864211007687
bibr42-17562864211007687
bibr142-17562864211007687
bibr32-17562864211007687
bibr57-17562864211007687
bibr128-17562864211007687
bibr67-17562864211007687
bibr143-17562864211007687
bibr31-17562864211007687
bibr58-17562864211007687
bibr153-17562864211007687
bibr28-17562864211007687
bibr152-17562864211007687
bibr68-17562864211007687
bibr41-17562864211007687
bibr8-17562864211007687
bibr59-17562864211007687
bibr79-17562864211007687
bibr94-17562864211007687
bibr81-17562864211007687
bibr74-17562864211007687
bibr123-17562864211007687
bibr103-17562864211007687
bibr110-17562864211007687
bibr3-17562864211007687
bibr26-17562864211007687
bibr99-17562864211007687
bibr39-17562864211007687
bibr157-17562864211007687
bibr86-17562864211007687
bibr66-17562864211007687
bibr137-17562864211007687
bibr19-17562864211007687
bibr46-17562864211007687
bibr117-17562864211007687
bibr135-17562864211007687
bibr115-17562864211007687
bibr145-17562864211007687
bibr125-17562864211007687
bibr14-17562864211007687
bibr105-17562864211007687
bibr34-17562864211007687
bibr150-17562864211007687
Ferber IA (bibr33-17562864211007687) 1996; 156
bibr155-17562864211007687
bibr160-17562864211007687
bibr140-17562864211007687
bibr130-17562864211007687
bibr120-17562864211007687
bibr54-17562864211007687
bibr64-17562864211007687
bibr44-17562864211007687
References_xml – volume: 5
  start-page: 271
  year: 2010
  end-page: 277
  article-title: Epstein–Barr virus infection and multiple sclerosis: a review
  publication-title: J Neuroimmune Pharmacol
– volume: 76
  start-page: 231
  year: 2014
  end-page: 240
  article-title: Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis
  publication-title: Ann Neurol
– volume: 101
  start-page: 143
  year: 2003
  end-page: 150
  article-title: Interferon-gamma switches monocyte differentiation from dendritic cells to macrophages
  publication-title: Blood
– volume: 1246
  start-page: 1
  year: 2011
  end-page: 10
  article-title: The establishment of early B cell tolerance in humans: lessons from primary immunodeficiency diseases
  publication-title: Ann N Y Acad Sci
– volume: 31
  start-page: 91
  year: 1991
  end-page: 96
  article-title: Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls
  publication-title: J Neuroimmunol
– volume: 192
  start-page: 1075
  year: 2000
  end-page: 1080
  article-title: Resistance to experimental autoimmune encephalomyelitis in mice lacking the Cc chemokine receptor (Ccr2)
  publication-title: J Exp Med
– volume: 113
  start-page: 7864
  year: 2016
  end-page: 7869
  article-title: Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins
  publication-title: Proc Natl Acad Sci U S A
– volume: 170
  start-page: 2153
  year: 2003
  end-page: 2160
  article-title: Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system
  publication-title: J Immunol
– volume: 132
  start-page: 3329
  year: 2009
  end-page: 3341
  article-title: Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
  publication-title: Brain
– volume: 182
  start-page: 6508
  year: 2009
  end-page: 6516
  article-title: Sialoadhesin-positive macrophages bind regulatory T cells, negatively controlling their expansion and autoimmune disease progression
  publication-title: J Immunol
– volume: 134
  start-page: 2755
  year: 2011
  end-page: 2771
  article-title: Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
  publication-title: Brain
– volume: 88
  start-page: 103
  year: 2018
  end-page: 113
  article-title: Signaling via toll-like receptor 4 and CD40 in B cells plays a regulatory role in the pathogenesis of multiple sclerosis through interleukin-10 production
  publication-title: J Autoimmun
– volume: 16
  start-page: 517
  year: 1996
  end-page: 528
  article-title: Myelin-stimulated macrophages release neurotrophic factors for adult dorsal root ganglion neurons in culture
  publication-title: Cell Mol Neurobiol
– volume: 47
  start-page: 707
  year: 2000
  end-page: 717
  article-title: Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination
  publication-title: Ann Neurol
– volume: 112
  start-page: 197
  year: 2001
  end-page: 205
  article-title: Monocytes in multiple sclerosis: phenotype and cytokine profile
  publication-title: J Neuroimmunol
– volume: 148
  start-page: 375
  year: 1996
  end-page: 382
  article-title: Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin-12. Preferential expansion of interferon-gamma-producing cells and increased expression of macrophage-associated inducible nitric oxide synthase as immunomodulatory mechanisms
  publication-title: Am J Pathol
– volume: 151
  start-page: 127
  year: 2014
  end-page: 135
  article-title: Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulations
  publication-title: Clin Immunol
– volume: 415
  start-page: 536
  year: 2002
  end-page: 541
  article-title: Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
  publication-title: Nature
– volume: 66
  start-page: 739
  year: 2009
  end-page: 753
  article-title: Multiple sclerosis: distribution of inflammatory cells in newly forming lesions
  publication-title: Ann Neurol
– volume: 175
  start-page: 85
  year: 2018
  end-page: 100
  article-title: Memory B cells activate brain-homing, autoreactive CD4 T cells in multiple sclerosis
  publication-title: Cell
– volume: 376
  start-page: 221
  year: 2017
  end-page: 234
  article-title: Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis
  publication-title: N Engl J Med
– volume: 357
  start-page: 851
  year: 2007
  end-page: 862
  article-title: Risk alleles for multiple sclerosis identified by a genomewide study
  publication-title: N Engl J Med
– volume: 85
  start-page: 78
  year: 2017
  end-page: 97
  article-title: Modulation of inflammatory and immune responses by vitamin D
  publication-title: J Autoimmun
– volume: 63
  start-page: 290
  year: 2001
  end-page: 302
  article-title: T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls
  publication-title: J Neurosci Res
– volume: 21
  start-page: 1811
  year: 2015
  end-page: 1822
  article-title: FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis
  publication-title: Mult Scler
– volume: 13
  start-page: 423
  year: 2007
  end-page: 431
  article-title: Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation
  publication-title: Nat Med
– volume: 124
  start-page: 132
  year: 1989
  end-page: 143
  article-title: Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype
  publication-title: Cell Immunol
– volume: 129
  start-page: 1953
  year: 2006
  end-page: 1971
  article-title: Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research
  publication-title: Brain
– volume: 49
  start-page: 595
  year: 2018
  end-page: 613
  article-title: Developmental and functional heterogeneity of monocytes
  publication-title: Immunity
– volume: 92
  start-page: 509
  year: 2014
  end-page: 517
  article-title: Expansion and preferential activation of the CD14 CD16 monocyte subset during multiple sclerosis
  publication-title: Immunol Cell Biol
– volume: 115
  start-page: 187
  year: 2005
  end-page: 194
  article-title: Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS
  publication-title: J Clin Invest
– volume: 237
  start-page: 73
  year: 2011
  end-page: 79
  article-title: Parenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains
  publication-title: J Neuroimmunol
– volume: 14
  start-page: 164
  year: 2004
  end-page: 174
  article-title: Detection of ectopic B-cell follicles with Germinal centers in the meninges of patients with secondary progressive multiple sclerosis
  publication-title: Brain Pathology
– volume: 259
  start-page: 231
  year: 2014
  end-page: 244
  article-title: Regulatory T cells in autoimmune neuroinflammation
  publication-title: Immunol Rev
– volume: 142
  start-page: 120
  year: 2019
  end-page: 132
  article-title: Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis
  publication-title: Brain
– volume: 5
  start-page: 101
  year: 1999
  end-page: 104
  article-title: Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis
  publication-title: Mult Scler
– volume: 60
  start-page: 3563
  year: 2009
  end-page: 3571
  article-title: Depletion of functionally active CD20+ T cells by rituximab treatment
  publication-title: Arthritis Rheum
– volume: 67
  start-page: 452
  year: 2010
  end-page: 461
  article-title: Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
  publication-title: Ann Neurol
– article-title: Immunologic effects of vitamin D on human health and disease
  publication-title: Nutrients
– volume: 172
  start-page: 146
  year: 2008
  end-page: 155
  article-title: Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis
  publication-title: Am J Pathol
– volume: 28
  start-page: 18
  year: 2008
  end-page: 28
  article-title: Sites and stages of autoreactive B cell activation and regulation
  publication-title: Immunity
– volume: 129
  start-page: 517
  year: 2006
  end-page: 526
  article-title: Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis
  publication-title: Brain
– volume: 4
  start-page: 201
  year: 1983
  end-page: 221
  article-title: Multiple sclerosis: distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages
  publication-title: J Neuroimmunol
– volume: 153
  start-page: 85
  year: 1996
  end-page: 106
  article-title: The role of CD40 ligand in costimulation and T-cell activation
  publication-title: Immunol Rev
– volume: 188
  start-page: 3188
  year: 2012
  end-page: 3198
  article-title: A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand
  publication-title: J Immunol
– volume: 153
  start-page: 362
  year: 2013
  end-page: 375
  article-title: Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal
  publication-title: Cell
– volume: 68
  start-page: 477
  year: 2010
  end-page: 493
  article-title: A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
  publication-title: Ann Neurol
– article-title: Expansion of neutrophils and classical and nonclassical monocytes as a hallmark in relapsing-remitting multiple sclerosis
  publication-title: Front Immunol
– volume: 19
  start-page: 578
  year: 1986
  end-page: 587
  article-title: Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions
  publication-title: Ann Neurol
– volume: 95
  year: 2020
  article-title: Pathologic correlates of the magnetization transfer ratio in multiple sclerosis
  publication-title: Neurology
– volume: 90
  start-page: 113
  year: 1998
  end-page: 121
  article-title: A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation
  publication-title: J Neuroimmunol
– volume: 279
  start-page: 21
  year: 2009
  end-page: 25
  article-title: The prognostic significance of cerebrospinal fluid in multiple sclerosis
  publication-title: J Neurol Sci
– article-title: Toward a refined definition of monocyte subsets
  publication-title: Front Immunol
– volume: 55
  start-page: 458
  year: 2004
  end-page: 468
  article-title: Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion
  publication-title: Ann Neurol
– volume: 372
  start-page: 1502
  year: 2008
  end-page: 1517
  article-title: Multiple sclerosis
  publication-title: Lancet
– volume: 119
  start-page: 145
  year: 2001
  end-page: 149
  article-title: Increased percentage of IL-12+ monocytes in the blood correlates with the presence of active MRI lesions in MS
  publication-title: J Neuroimmunol
– volume: 96
  start-page: 160
  year: 2018
  end-page: 174
  article-title: Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis
  publication-title: Immunol Cell Biol
– volume: 35
  start-page: 3343
  year: 2005
  end-page: 3352
  article-title: Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis
  publication-title: Eur J Immunol
– volume: 491
  start-page: 264
  year: 2012
  end-page: 268
  article-title: Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions
  publication-title: Nature
– volume: 65
  start-page: 499
  year: 2009
  end-page: 509
  article-title: T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta
  publication-title: Ann Neurol
– article-title: IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis
  publication-title: J Clin Invest
– volume: 70
  start-page: 87
  year: 1996
  end-page: 90
  article-title: Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis
  publication-title: J Neuroimmunol
– volume: 199
  start-page: 971
  year: 2004
  end-page: 979
  article-title: Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis
  publication-title: J Exp Med
– volume: 68
  start-page: 337
  year: 1983
  end-page: 343
  article-title: CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies
  publication-title: Acta Neurol Scand
– volume: 209
  start-page: 1001
  year: 2012
  end-page: 1010
  article-title: B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
  publication-title: J Exp Med
– volume: 12
  year: 2017
  article-title: Absence of antibodies against KIR4.1 in multiple sclerosis: a three-technique approach and systematic review
  publication-title: PLoS One
– volume: 10
  start-page: 5722
  year: 2019
  article-title: IL-17 CD8 T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis
  publication-title: Nat Commun
– volume: 17
  start-page: 303
  year: 2011
  end-page: 311
  article-title: Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM
  publication-title: Mult Scler
– volume: 317
  start-page: 666
  year: 2007
  end-page: 670
  article-title: Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior
  publication-title: Science
– volume: 476
  start-page: 214
  year: 2011
  end-page: 219
  article-title: Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
  publication-title: Nature
– volume: 37
  start-page: 1097
  year: 1987
  end-page: 1102
  article-title: Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system
  publication-title: Neurology
– volume: 6
  start-page: 1133
  year: 2005
  end-page: 1141
  article-title: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
  publication-title: Nat Immunol
– volume: 198
  start-page: 3245
  year: 2017
  end-page: 3254
  article-title: Antibody-independent function of human B cells contributes to antifungal T cell responses
  publication-title: J Immunol
– volume: 7
  start-page: 311
  year: 2006
  end-page: 317
  article-title: Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2
  publication-title: Nat Immunol
– volume: 378
  start-page: 1779
  year: 2011
  end-page: 1787
  article-title: Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
  publication-title: Lancet
– volume: 358
  start-page: 676
  year: 2008
  end-page: 688
  article-title: B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
  publication-title: N Engl J Med
– volume: 178
  start-page: 6092
  year: 2007
  end-page: 6099
  article-title: Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis
  publication-title: J Immunol
– volume: 54
  start-page: 7567
  year: 2017
  end-page: 7584
  article-title: Role of microglia in neurological disorders and their potentials as a therapeutic target
  publication-title: Mol Neurobiol
– volume: 53
  start-page: 41
  year: 2012
  end-page: 57
  article-title: The three human monocyte subsets: implications for health and disease
  publication-title: Immunol Res
– volume: 262
  start-page: 18
  year: 2014
  end-page: 27
  article-title: Th17 cells in central nervous system autoimmunity
  publication-title: Exp Neurol
– volume: 3
  start-page: 259
  year: 2007
  end-page: 268
  article-title: Natalizumab: a new treatment for relapsing remitting multiple sclerosis
  publication-title: Ther Clin Risk Manag
– volume: 130
  start-page: 1089
  year: 2007
  end-page: 1104
  article-title: Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology
  publication-title: Brain
– volume: 172
  start-page: 3893
  year: 2004
  end-page: 3904
  article-title: Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis
  publication-title: J Immunol
– volume: 16
  start-page: 1211
  year: 2013
  end-page: 1218
  article-title: M2 microglia/macrophages drive oligodendrocyte differentiation during CNS remyelination
  publication-title: Nat Neurosci
– article-title: Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism
  publication-title: Cell
– volume: 192
  start-page: 2551
  year: 2014
  end-page: 2563
  article-title: Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases
  publication-title: J Immunol
– volume: 7
  year: 2015
  article-title: Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy
  publication-title: Sci Transl Med
– volume: 9
  start-page: 824
  year: 2009
  end-page: 830
  article-title: Interferon-beta modifies the peripheral blood cell cytokine secretion in patients with multiple sclerosis
  publication-title: Int Immunopharmacol
– volume: 8
  start-page: 753
  year: 2017
  article-title: Th1 and Th17 cells and associated cytokines discriminate among clinically isolated syndrome and multiple sclerosis phenotypes
  publication-title: Front Immunol
– volume: 117
  start-page: 25690
  year: 2020
  end-page: 25699
  article-title: B cells reappear less mature and more activated after their anti-CD20–mediated depletion in multiple sclerosis
  publication-title: Proc Natl Acad Sci U S A
– volume: 71
  start-page: 1421
  year: 2014
  end-page: 1428
  article-title: The effect of glatiramer acetate therapy on functional properties of B cells from patients with relapsing-remitting multiple sclerosis
  publication-title: JAMA Neurol
– volume: 196
  start-page: 1558
  year: 2016
  end-page: 1567
  article-title: Pivotal role for CD16 monocytes in immune surveillance of the central nervous system
  publication-title: J Immunol
– volume: 34
  start-page: 213
  year: 2011
  end-page: 223
  article-title: Type I interferon inhibits interleukin-1 production and inflammasome activation
  publication-title: Immunity
– volume: 156
  start-page: 123
  year: 2004
  end-page: 131
  article-title: Early administration of IL-12 suppresses EAE through induction of interferon-gamma
  publication-title: J Neuroimmunol
– volume: 367
  start-page: 115
  year: 2012
  end-page: 123
  article-title: Potassium channel KIR4.1 as an immune target in multiple sclerosis
  publication-title: N Engl J Med
– volume: 106
  start-page: 4355
  year: 2009
  end-page: 4359
  article-title: Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis
  publication-title: Proc Natl Acad Sci U S A
– volume: 70
  start-page: 40
  year: 2016
  end-page: 51
  article-title: Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with multiple sclerosis
  publication-title: J Autoimmun
– article-title: Ocrelizumab depletes CD20+ T cells in multiple sclerosis patients
  publication-title: Cells
– volume: 216
  start-page: 359
  year: 1999
  end-page: 368
  article-title: Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation
  publication-title: Dev Biol
– volume: 557
  start-page: 724
  year: 2018
  end-page: 728
  article-title: Microglial control of astrocytes in response to microbial metabolites
  publication-title: Nature
– volume: 10
  start-page: 35
  year: 2013
  article-title: Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status
  publication-title: J Neuroinflammation
– volume: 238
  start-page: 87
  year: 2011
  end-page: 95
  article-title: Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis
  publication-title: J Neuroimmunol
– volume: 9
  start-page: 599
  year: 2010
  end-page: 612
  article-title: Vitamin D and multiple sclerosis
  publication-title: Lancet Neurol
– volume: 156
  start-page: 5
  year: 1996
  end-page: 7
  article-title: Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE)
  publication-title: J Immunol
– volume: 9
  start-page: 3116
  year: 2018
  article-title: Pathogenic mechanisms associated with different clinical courses of multiple sclerosis
  publication-title: Front Immunol
– volume: 49
  start-page: 102802
  year: 2021
  article-title: Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosis
  publication-title: Mult Scler Relat Disord
– volume: 99
  start-page: 2664
  year: 1997
  end-page: 2671
  article-title: Increased CD80 B cells in active multiple sclerosis and reversal by interferon beta-1b therapy
  publication-title: J Clin Invest
– volume: 2
  year: 2015
  article-title: Myeloid cells as target of fingolimod action in multiple sclerosis
  publication-title: Neurol Neuroimmunol Neuroinflamm
– volume: 24
  start-page: 584
  year: 2003
  end-page: 588
  article-title: Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases
  publication-title: Trends Immunol
– volume: 201
  start-page: 233
  year: 2005
  end-page: 240
  article-title: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
  publication-title: J Exp Med
– volume: 176
  year: 2019
  article-title: Recirculating intestinal IgA-producing cells regulate neuroinflammation via IL-10
  publication-title: Cell
– volume: 64
  start-page: 187
  year: 2008
  end-page: 199
  article-title: Helminth infections associated with multiple sclerosis induce regulatory B cells
  publication-title: Ann Neurol
– volume: 177
  start-page: 57
  year: 1993
  end-page: 68
  article-title: Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma
  publication-title: J Exp Med
– article-title: Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis
  publication-title: Neurol Neuroimmunol Neuroinflamm
– volume: 192
  start-page: 3607
  year: 2014
  end-page: 3617
  article-title: B cell antigen presentation in the initiation of follicular helper T cell and germinal center differentiation
  publication-title: J Immunol
– volume: 193
  start-page: 580
  year: 2014
  end-page: 586
  article-title: Rituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients
  publication-title: J Immunol
– volume: 5
  start-page: 170
  year: 1999
  end-page: 175
  article-title: Identification of autoantibodies associated with myelin damage in multiple sclerosis
  publication-title: Nat Med
– volume: 4
  start-page: 653
  year: 1948
  end-page: 662
  article-title: Quantitative estimation of the albumin and gamma globulin in normal and pathologic cerebrospinal fluid by immunochemical methods
  publication-title: Am J Med
– volume: 359
  start-page: 684
  year: 2018
  end-page: 688
  article-title: Defective cholesterol clearance limits remyelination in the aged central nervous system
  publication-title: Science
– volume: 9
  start-page: 394
  year: 2013
  end-page: 404
  article-title: Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis
  publication-title: Nat Rev Neurol
– volume: 7
  year: 2015
  article-title: Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis
  publication-title: Sci Transl Med
– volume: 115
  year: 2010
  article-title: Comparison of gene expression profiles between human and mouse monocyte subsets
  publication-title: Blood
– volume: 172
  start-page: 7144
  year: 2004
  end-page: 7153
  article-title: Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis
  publication-title: J Immunol
– volume: 17
  start-page: 673
  year: 2011
  end-page: 675
  article-title: Identification of T helper type 1–like, Foxp3+ regulatory T cells in human autoimmune disease
  publication-title: Nat Med
– volume: 219
  start-page: 55
  year: 1950
  end-page: 64
  article-title: A study of the crystalline albumin, gamma globulin and total protein in the cerebrospinal fluid of 100 cases of multiple sclerosis and in other diseases
  publication-title: Am J Med Sci
– volume: 200
  start-page: 79
  year: 2004
  end-page: 87
  article-title: Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis
  publication-title: J Exp Med
– volume: 194
  start-page: 2110
  year: 2015
  end-page: 2116
  article-title: IFN-β treatment requires B cells for efficacy in neuroautoimmunity
  publication-title: J Immunol
– article-title: Intrathecal inflammation in progressive multiple sclerosis
  publication-title: Int J Mol Sci
– volume: 301
  start-page: 1374
  year: 2003
  end-page: 1377
  article-title: Predominant autoantibody production by early human B cell precursors
  publication-title: Science
– volume: 21
  start-page: 1485
  year: 2015
  end-page: 1495
  article-title: Over-the-counter anti-oxidant therapies for use in multiple sclerosis: a systematic review
  publication-title: Mult Scler
– volume: 123
  start-page: 2737
  year: 2013
  end-page: 2741
  article-title: Specific peripheral B cell tolerance defects in patients with multiple sclerosis
  publication-title: J Clin Invest
– volume: 43
  start-page: 817
  year: 2015
  end-page: 829
  article-title: Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine
  publication-title: Immunity
– volume: 3
  start-page: 27
  year: 2016
  end-page: 41
  article-title: Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis
  publication-title: Ann Clin Transl Neurol
– volume: 4
  start-page: 143
  year: 2013
  article-title: PD-1 interaction with PD-L1 but not PD-L2 on B-cells mediates protective effects of estrogen against EAE
  publication-title: J Clin Cell Immunol
– volume: 242
  start-page: 39
  year: 2012
  end-page: 46
  article-title: IFN-β induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis
  publication-title: J Neuroimmunol
– volume: 19
  start-page: 1323
  year: 2013
  end-page: 1329
  article-title: Childhood body mass index and multiple sclerosis risk: a long-term cohort study
  publication-title: Mult Scler
– volume: 192
  start-page: 899
  year: 2000
  end-page: 906
  article-title: Cc chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis
  publication-title: J Exp Med
– volume: 14
  start-page: 447
  year: 2014
  end-page: 462
  article-title: Ectopic lymphoid-like structures in infection, cancer and autoimmunity
  publication-title: Nat Rev Immunol
– volume: 3
  start-page: 944
  year: 2002
  end-page: 950
  article-title: B cells regulate autoimmunity by provision of IL-10
  publication-title: Nat Immunol
– volume: 8
  start-page: 500
  year: 2002
  end-page: 508
  article-title: Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
  publication-title: Nat Med
– volume: 7
  year: 2012
  article-title: Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients
  publication-title: PLoS One
– article-title: Gut microbiota–specific IgA B cells traffic to the CNS in active multiple sclerosis
  publication-title: Sci Immunol
– volume: 12
  year: 2019
  article-title: Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis
  publication-title: Ther Adv Neurol Disord
– volume: 125
  start-page: 595
  year: 2013
  end-page: 608
  article-title: Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons
  publication-title: Acta Neuropathol
– volume: 13
  start-page: 507
  year: 2012
  end-page: 514
  article-title: Will the real multiple sclerosis please stand up?
  publication-title: Nat Rev Neurosci
– volume: 61
  start-page: 504
  year: 2007
  end-page: 513
  article-title: Environmental risk factors for multiple sclerosis. Part II: noninfectious factors
  publication-title: Ann Neurol
– volume: 6
  start-page: 381
  year: 2011
  end-page: 388
  article-title: Glatiramer acetate modulates TNF-α and IL-10 secretion in microglia and promotes their phagocytic activity
  publication-title: J Neuroimmune Pharmacol
– volume: 140
  start-page: 1900
  year: 2017
  end-page: 1913
  article-title: Loss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis
  publication-title: Brain
– volume: 102
  start-page: 6449
  year: 2005
  end-page: 6454
  article-title: Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3
  publication-title: Proc Natl Acad Sci U S A
– volume: 61
  start-page: 321
  year: 2003
  end-page: 326
  article-title: Neuropathology of multiple sclerosis-new concepts
  publication-title: Brain Res Bull
– volume: 246
  start-page: 85
  year: 2012
  end-page: 95
  article-title: Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro
  publication-title: J Neuroimmunol
– volume: 15
  start-page: 300
  year: 2018
  article-title: Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis
  publication-title: J Neuroinflammation
– volume: 261
  start-page: 130
  year: 2014
  end-page: 143
  article-title: Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases
  publication-title: J Neurol
– volume: 25
  start-page: 63
  year: 2019
  end-page: 71
  article-title: Monomethyl fumarate treatment impairs maturation of human myeloid dendritic cells and their ability to activate T cells
  publication-title: Mult Scler
– volume: 66
  start-page: 390
  year: 2009
  end-page: 402
  article-title: Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis
  publication-title: Ann Neurol
– volume: 116
  start-page: 25800
  year: 2019
  end-page: 25807
  article-title: Anti-CD20 therapy depletes activated myelin-specific CD8+ T cells in multiple sclerosis
  publication-title: Proc Natl Acad Sci U S A
– volume: 169
  start-page: 4712
  year: 2002
  end-page: 4716
  article-title: Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis
  publication-title: J Immunol
– volume: 63
  start-page: 395
  year: 2008
  end-page: 400
  article-title: Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial
  publication-title: Ann Neurol
– volume: 309
  start-page: 88
  year: 2017
  end-page: 99
  article-title: B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro
  publication-title: J Neuroimmunol
– volume: 193
  start-page: 170
  year: 2014
  end-page: 176
  article-title: A role for intrathymic B cells in the generation of natural regulatory T cells
  publication-title: J Immunol
– volume: 110
  start-page: 493
  year: 2002
  end-page: 497
  article-title: Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12
  publication-title: J Clin Invest
– ident: bibr70-17562864211007687
  doi: 10.1126/science.1086907
– ident: bibr11-17562864211007687
  doi: 10.1177/1352458513483889
– ident: bibr14-17562864211007687
  doi: 10.1016/S1474-4422(10)70086-7
– ident: bibr93-17562864211007687
  doi: 10.1002/ana.21363
– ident: bibr92-17562864211007687
  doi: 10.1056/NEJMoa0706383
– ident: bibr81-17562864211007687
  doi: 10.1111/j.1749-6632.2011.06347.x
– volume: 148
  start-page: 375
  year: 1996
  ident: bibr24-17562864211007687
  publication-title: Am J Pathol
– ident: bibr57-17562864211007687
  doi: 10.1002/ana.410190610
– ident: bibr147-17562864211007687
  doi: 10.1038/nn.3469
– ident: bibr137-17562864211007687
  doi: 10.1038/icb.2014.15
– ident: bibr148-17562864211007687
  doi: 10.1007/BF02150231
– ident: bibr132-17562864211007687
  doi: 10.1126/science.1142883
– ident: bibr59-17562864211007687
  doi: 10.1172/JCI63681
– ident: bibr154-17562864211007687
  doi: 10.1177/1352458515574895
– ident: bibr96-17562864211007687
  doi: 10.4049/jimmunol.178.10.6092
– ident: bibr108-17562864211007687
  doi: 10.1016/j.clim.2014.02.001
– ident: bibr141-17562864211007687
  doi: 10.1093/brain/awx113
– ident: bibr32-17562864211007687
  doi: 10.4049/jimmunol.170.4.2153
– ident: bibr63-17562864211007687
  doi: 10.1172/JCI22833
– ident: bibr101-17562864211007687
  doi: 10.1186/s12974-018-1334-y
– ident: bibr112-17562864211007687
  doi: 10.4049/jimmunol.1400118
– ident: bibr89-17562864211007687
  doi: 10.4049/jimmunol.1103354
– ident: bibr13-17562864211007687
  doi: 10.1007/s11481-010-9201-3
– ident: bibr15-17562864211007687
  doi: 10.1016/j.jaut.2017.07.007
– ident: bibr118-17562864211007687
  doi: 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q
– ident: bibr82-17562864211007687
  doi: 10.1172/JCI68775
– ident: bibr76-17562864211007687
  doi: 10.1002/ana.22230
– ident: bibr126-17562864211007687
  doi: 10.1182/blood-2009-07-235028
– ident: bibr39-17562864211007687
  doi: 10.3389/fimmu.2017.00753
– ident: bibr98-17562864211007687
  doi: 10.4049/jimmunol.1601572
– ident: bibr130-17562864211007687
  doi: 10.1084/jem.192.6.899
– ident: bibr157-17562864211007687
  doi: 10.1002/acn3.270
– ident: bibr149-17562864211007687
  doi: 10.1038/s41586-018-0119-x
– ident: bibr150-17562864211007687
  doi: 10.1007/s12035-016-0245-0
– ident: bibr105-17562864211007687
  doi: 10.1016/j.jaut.2017.10.011
– ident: bibr161-17562864211007687
  doi: 10.1177/1756286418819074
– ident: bibr56-17562864211007687
  doi: 10.1038/nrneurol.2013.95
– ident: bibr20-17562864211007687
  doi: 10.1084/jem.20031579
– ident: bibr18-17562864211007687
  doi: 10.1002/1097-4547(20010201)63:3<290::AID-JNR1023>3.0.CO;2-4
– ident: bibr97-17562864211007687
  doi: 10.1002/ana.21939
– ident: bibr106-17562864211007687
  doi: 10.4049/jimmunol.1402029
– ident: bibr107-17562864211007687
  doi: 10.1001/jamaneurol.2014.1472
– ident: bibr136-17562864211007687
  doi: 10.4049/jimmunol.1302884
– ident: bibr109-17562864211007687
  doi: 10.1016/j.jaut.2016.03.012
– ident: bibr75-17562864211007687
  doi: 10.1093/brain/awm038
– ident: bibr27-17562864211007687
  doi: 10.1212/WNL.37.7.1097
– ident: bibr8-17562864211007687
  doi: 10.1038/nrn3275
– ident: bibr84-17562864211007687
  doi: 10.4049/jimmunol.1301284
– ident: bibr104-17562864211007687
  doi: 10.1002/ana.21438
– ident: bibr116-17562864211007687
  doi: 10.1016/j.msard.2021.102802
– ident: bibr122-17562864211007687
  doi: 10.1093/brain/awh707
– ident: bibr9-17562864211007687
  doi: 10.1056/NEJMoa073493
– volume: 156
  start-page: 5
  year: 1996
  ident: bibr33-17562864211007687
  publication-title: J Immunol
  doi: 10.4049/jimmunol.156.1.5
– ident: bibr5-17562864211007687
  doi: 10.1038/5532
– ident: bibr23-17562864211007687
  doi: 10.1016/0008-8749(89)90117-2
– ident: bibr139-17562864211007687
  doi: 10.3389/fimmu.2020.00594
– ident: bibr91-17562864211007687
  doi: 10.1016/j.cell.2018.11.035
– ident: bibr146-17562864211007687
  doi: 10.1126/science.aan4183
– ident: bibr49-17562864211007687
  doi: 10.1016/S0165-5728(96)00101-4
– ident: bibr121-17562864211007687
  doi: 10.1016/S0165-5728(01)00371-X
– ident: bibr36-17562864211007687
  doi: 10.1177/135245859900500206
– ident: bibr134-17562864211007687
  doi: 10.4049/jimmunol.1501960
– ident: bibr113-17562864211007687
  doi: 10.3390/cells8010012
– ident: bibr51-17562864211007687
  doi: 10.1016/j.cell.2020.02.035
– ident: bibr16-17562864211007687
  doi: 10.3390/nu12072097
– ident: bibr71-17562864211007687
  doi: 10.1016/j.immuni.2007.12.004
– ident: bibr45-17562864211007687
  doi: 10.1038/nm1564
– ident: bibr131-17562864211007687
  doi: 10.1016/j.cell.2013.03.010
– ident: bibr41-17562864211007687
  doi: 10.1016/j.expneurol.2014.03.009
– ident: bibr60-17562864211007687
  doi: 10.1097/00000441-195001000-00009
– ident: bibr155-17562864211007687
  doi: 10.1212/NXI.0000000000000157
– ident: bibr12-17562864211007687
  doi: 10.1002/ana.21141
– ident: bibr47-17562864211007687
  doi: 10.1111/imr.12169
– ident: bibr69-17562864211007687
  doi: 10.1016/j.jneuroim.2011.08.002
– ident: bibr74-17562864211007687
  doi: 10.1038/nri3700
– ident: bibr111-17562864211007687
  doi: 10.1002/art.24998
– ident: bibr115-17562864211007687
  doi: 10.1093/brain/awy301
– ident: bibr30-17562864211007687
  doi: 10.1016/j.jneuroim.2004.07.019
– ident: bibr80-17562864211007687
  doi: 10.1016/j.jneuroim.2017.05.004
– ident: bibr100-17562864211007687
  doi: 10.1126/scitranslmed.aab4176
– ident: bibr77-17562864211007687
  doi: 10.1093/brain/awr182
– ident: bibr1-17562864211007687
  doi: 10.1093/brain/awl075
– ident: bibr6-17562864211007687
  doi: 10.1002/ana.20016
– ident: bibr2-17562864211007687
  doi: 10.1016/S0140-6736(08)61620-7
– ident: bibr58-17562864211007687
  doi: 10.1038/s41467-019-13731-z
– ident: bibr114-17562864211007687
  doi: 10.1073/pnas.1915309116
– ident: bibr160-17562864211007687
  doi: 10.1177/1352458515601513
– ident: bibr99-17562864211007687
  doi: 10.1084/jem.20111675
– ident: bibr44-17562864211007687
  doi: 10.4049/jimmunol.169.9.4712
– ident: bibr19-17562864211007687
  doi: 10.4049/jimmunol.172.6.3893
– ident: bibr25-17562864211007687
  doi: 10.1038/415536a
– ident: bibr124-17562864211007687
  doi: 10.1007/s12026-012-8297-3
– ident: bibr117-17562864211007687
  doi: 10.1016/S0361-9230(03)00095-9
– ident: bibr72-17562864211007687
  doi: 10.1371/journal.pone.0175538
– ident: bibr78-17562864211007687
  doi: 10.1111/j.1750-3639.2004.tb00049.x
– ident: bibr79-17562864211007687
  doi: 10.1016/j.jneuroim.2012.02.015
– ident: bibr102-17562864211007687
  doi: 10.1038/ni833
– ident: bibr135-17562864211007687
  doi: 10.1007/s00415-013-7145-2
– ident: bibr152-17562864211007687
  doi: 10.1073/pnas.0812183106
– ident: bibr38-17562864211007687
  doi: 10.2353/ajpath.2008.070690
– ident: bibr7-17562864211007687
  doi: 10.1002/ana.21800
– ident: bibr67-17562864211007687
  doi: 10.1111/j.1600-0404.1983.tb04841.x
– ident: bibr94-17562864211007687
  doi: 10.1016/S0140-6736(11)61649-8
– ident: bibr17-17562864211007687
  doi: 10.1016/j.it.2003.09.005
– ident: bibr123-17562864211007687
  doi: 10.1016/j.jneuroim.2011.06.006
– ident: bibr128-17562864211007687
  doi: 10.1182/blood-2002-04-1164
– ident: bibr145-17562864211007687
  doi: 10.1006/dbio.1999.9466
– ident: bibr62-17562864211007687
  doi: 10.1016/S0002-9343(48)90389-1
– ident: bibr87-17562864211007687
  doi: 10.1016/j.cell.2018.08.011
– ident: bibr142-17562864211007687
  doi: 10.1186/1742-2094-10-35
– ident: bibr3-17562864211007687
  doi: 10.3389/fimmu.2018.03116
– ident: bibr159-17562864211007687
  doi: 10.1177/1352458517740213
– ident: bibr10-17562864211007687
  doi: 10.1038/nature10251
– ident: bibr119-17562864211007687
  doi: 10.1212/WNL.0000000000010909
– ident: bibr73-17562864211007687
  doi: 10.1073/pnas.1522730113
– ident: bibr125-17562864211007687
  doi: 10.3389/fimmu.2013.00023
– ident: bibr151-17562864211007687
  doi: 10.4049/jimmunol.172.11.7144
– ident: bibr88-17562864211007687
  doi: 10.4172/2155-9899.1000143
– ident: bibr53-17562864211007687
  doi: 10.1212/NXI.0000000000000183
– ident: bibr86-17562864211007687
  doi: 10.1172/JCI119455
– ident: bibr144-17562864211007687
  doi: 10.4049/jimmunol.0804247
– ident: bibr42-17562864211007687
  doi: 10.1002/ana.21748
– ident: bibr65-17562864211007687
  doi: 10.1002/ana.24190
– ident: bibr138-17562864211007687
  doi: 10.1111/imcb.1025
– ident: bibr127-17562864211007687
  doi: 10.1038/ni1309
– ident: bibr156-17562864211007687
  doi: 10.1016/j.immuni.2011.02.006
– ident: bibr22-17562864211007687
  doi: 10.1038/nm0502-500
– ident: bibr46-17562864211007687
  doi: 10.1002/eji.200526065
– ident: bibr140-17562864211007687
  doi: 10.1007/s00401-013-1082-0
– ident: bibr26-17562864211007687
  doi: 10.1084/jem.20031819
– ident: bibr21-17562864211007687
  doi: 10.1016/0165-5728(83)90036-X
– ident: bibr129-17562864211007687
  doi: 10.1084/jem.192.7.1075
– ident: bibr4-17562864211007687
  doi: 10.3390/ijms21218217
– ident: bibr28-17562864211007687
  doi: 10.1084/jem.177.1.57
– ident: bibr48-17562864211007687
  doi: 10.1038/nm.2389
– ident: bibr50-17562864211007687
  doi: 10.1016/j.immuni.2015.09.007
– ident: bibr66-17562864211007687
  doi: 10.1016/0165-5728(91)90014-X
– ident: bibr143-17562864211007687
  doi: 10.1016/S0165-5728(98)00145-3
– ident: bibr29-17562864211007687
  doi: 10.2147/tcrm.2007.3.2.259
– ident: bibr120-17562864211007687
  doi: 10.1016/S0165-5728(00)00396-9
– ident: bibr133-17562864211007687
  doi: 10.1016/j.immuni.2018.10.005
– ident: bibr158-17562864211007687
  doi: 10.1371/journal.pone.0051867
– ident: bibr83-17562864211007687
  doi: 10.4049/jimmunol.1302519
– ident: bibr34-17562864211007687
  doi: 10.1084/jem.20041257
– ident: bibr43-17562864211007687
  doi: 10.1126/scitranslmed.aaa8038
– ident: bibr153-17562864211007687
  doi: 10.1007/s11481-010-9248-1
– ident: bibr31-17562864211007687
  doi: 10.1172/JCI0215751
– ident: bibr90-17562864211007687
  doi: 10.1126/sciimmunol.abc7191
– ident: bibr37-17562864211007687
  doi: 10.1002/ana.21652
– ident: bibr54-17562864211007687
  doi: 10.1016/j.intimp.2009.03.004
– ident: bibr55-17562864211007687
  doi: 10.1016/j.jneuroim.2011.10.014
– ident: bibr85-17562864211007687
  doi: 10.1111/j.1600-065X.1996.tb00921.x
– ident: bibr40-17562864211007687
  doi: 10.1093/brain/awp289
– ident: bibr61-17562864211007687
  doi: 10.1016/j.jns.2008.12.029
– ident: bibr110-17562864211007687
  doi: 10.1073/pnas.2012249117
– ident: bibr95-17562864211007687
  doi: 10.1056/NEJMoa1601277
– ident: bibr103-17562864211007687
  doi: 10.1038/nature11501
– ident: bibr68-17562864211007687
  doi: 10.1056/NEJMoa1110740
– ident: bibr52-17562864211007687
  doi: 10.1073/pnas.0502187102
– ident: bibr35-17562864211007687
  doi: 10.1038/ni1261
– ident: bibr64-17562864211007687
  doi: 10.1177/1352458510386996
SSID ssj0062740
Score 2.5012133
SecondaryResourceType review_article
Snippet Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) that is characterised pathologically by demyelination, gliosis,...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
sage
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 17562864211007687
SubjectTerms Antigens
Autoantigens
Autoimmune Neurology
Central nervous system
Demyelination
Gliosis
Inflammation
Inflammatory diseases
Lymphocytes B
Lymphocytes T
Macrophages
Multiple sclerosis
Myeloid cells
Pathology
Phenotypes
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxQxEB9qC-KL-O3WKlsRBCG4-dqkT6JiaQv1ycK9LZsveyB7tXf9_zuTzW09Wvu42SxkMzOZXzKT3wB8QMiqCXozn6JkCh-Z48KwqJ1TPIXo-5zl-7M9OlMnMz0rB27Lkla5XhPzQh0Wns7IPyPSR99v0P98ufjLqGoURVdLCY0HsEPUZaTVZjZtuKiszHghUrdMWN2WqCYRLlGbsHTLk-dglNnwS5m-_y7MeTt18p_8r-ySDp_A44Il66-j8J_CVhyewcPTEi1_Du-Ph4QCHy8n1vOhXmcP1kvsj8OYL1_A2eGPX9-PWKmJwLyWYsVk4L0UzgsVDqRPTdRJxug8T6YxBrFa0AfKhMCdMqJ3to3GJaIV9IoHgh8vYXtYDPE11Ah1gnC4vUg2qJTQknsRbIjKCfRqXlfQrGek84UwnOpW_Ol44Qi_NYkVfJo-uRjZMu7r_I2meepIRNe5YXH5uyt2g748ON5I3wTrVG9U75TjTvStDq5F7FrB3lpIXbG-ZXejKxXsT6_RbigY0g9xcYV9EHgiNjRWVvBqlOk0EimJw4bbCsyGtDeGuvlmmJ9nbm6LixoukhV8JL24GdJ_Z2H3_h94A48EZdHkQ5892F5dXsW3CINW7l3W9WtiMP5Z
  priority: 102
  providerName: ProQuest
– databaseName: Sage Journals GOLD Open Access 2024
  dbid: AFRWT
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3daxQxEB_qFcQXsVbt1lZWEQQhdvO12T6VKh5V0AdpsW_L5qs9sHuld_fQ_74zu9lrj1bxcZNZMkwmmV8yHwF4j5BVE_RmLgbJFH4yy4VhQVurePTBNV2U78_y6ER9P9WnazAdcmGSBGefKKwKOeo2a1rddBu9l5yMe2jzKKVS0emFXEnmYDG_qPvr7uFVDWoh__TiglzbjgIir9mQ3vYI1oUptRjB-uH41-_jYfOml2j6HEpdMhohOUIfHHTFlHUV_x-CqfejLe-EjHVWbPwMnib4mR_2-rIBa6F9Do9_JAf7Jrz71kbUkT6fMZ-0-RBwmM-QHtmYzF7Ayfjr8Zcjlp5RYE5LMWfS80YK64Ty-9LFIugoQ7COR1MYg_DO631lvOdWGdHYqgzGRqpE6BT3hFhewqidtmELckRHXlg8kcTKqxhx8TfCVz4oK9AQOp1BMUikdqnGOD118afmqaz4PSFm8HH5y2VfYONfxJ9JzEtCqo3dNUyvzuq01ND8e8sL6QpfWdUY1VhluRVNqb0tEe5msDNMUj2oW40HSYSWOPllBm-X3bjUyH_StGG6QBrEqggnTSUzeNXP6ZITKansDa8yMCuzvcLqak87Oe_KeVe4D-K-msEH0otblv4qhe3_pnwNTwTF4HRXRjswml8twi6CqLl9kxT_BjaEEhc
  priority: 102
  providerName: SAGE Publications
Title Inflammation in multiple sclerosis
URI https://journals.sagepub.com/doi/full/10.1177/17562864211007687
https://www.ncbi.nlm.nih.gov/pubmed/33948118
https://www.proquest.com/docview/2613247406
https://www.proquest.com/docview/2522392783
https://pubmed.ncbi.nlm.nih.gov/PMC8053832
https://doaj.org/article/badb103c0d8b4a74ab4b1b2a65db6977
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bS91AEB6qBfGl9KJtrD3EIghCaPaSbHzU4sEWKiKK5y3s7AUPSCw9x__vTC6nHrz0pU8h2Q0MM9mZbzOz3wDsEmQtGHpnLgaVabrNUEiThQJRi-iDs22V72l5cql_TorJg1ZfXBPW0QN3ivuG1qPIlct9hdoabVGjQGnLwmNJ4IW9L8W8YTPV-WBuKDPkMJleiWIkH8HUvNvh1JNZikItWf9TCPNxoeSDaq82AI3fwpseOaaHncTv4FVo3sParz43_gG-_mgimbc7iphOm3SoFUxnNJ_EmM424HJ8fPH9JOs7IGSuUHKeKS-skuik9gfKxTwUUYWATkSTG0PIzBcH2ngvUBtpsSqDwcgkgk4Lz2BjE1ab2yZ8gpSAjZdIm4lYeR0jrVsrfeWDRkkxzBUJ5INGatfTg3OXipta9Izgj5SYwP7ild8dN8ZLk49YzYuJTGvdPiBj172x638ZO4HtwUh1v9ZmNe0BCRWSwcsEdhbDtEo49WGbcHtHcwhmEhI0lUrgY2fThSRKMWONqBIwS9ZeEnV5pJlet0zcFbkwcokJ7PF38VekZ7Ww9T-08BnWJVfWtD-CtmF1_ucufCFoNMcRrJiJGcHrw_H51QVdj45Pz85H7dq4BxMHCkA
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwEB6VIkFfEHcDBQICISFFxFfsPiDEVe3S46mV9i3EV7sSypbuVlX_FL-RmVxlVehbH2M7kTMez3zjGc8AvEbIqgh6Zy4GkUl8zCzjOgvKWsmiD65qonz3itGB_D5RkxX43d-FobDKXiY2gtrPHJ2Rv0ekj7pfo_75ePwro6pR5F3tS2i0bLEdzs_QZJt_GH_F9X3D-da3_S-jrKsqkDkl-CITnlWCW8el3xQu5kFFEYJ1LOpca0Q7Xm1K7T2zUvPKmiJoGykxn5PMkwLH796Am6h4czL29GQw8KiMTXsBUxUZN6rovKiU4InauKFbpaxxfuklPdiUC_gXxr0cqvlXvFmjArfuwp0Ou6afWma7Byuhvg-3djvv_AN4Na4jMlh7GTKd1mkfrZjOcTxOYzp_CAfXQq1HsFrP6rAOKUIrzy2aM9F4GSNKjop744O0HLWoUwnkPUVK1yUopzoZP0vW5SS_RMQE3g2vHLfZOa4a_JnIPAykxNpNw-zksOz2KWIHb1kuXO6NlZWWlZWWWV4VytsCsXICG_0ild1un5cXvJnAy6Eb9yk5X6o6zE5xDAJdxKLaiAQet2s6zEQIypnDTAJ6abWXprrcU0-PmlzgBoUoCuUE3hJfXEzpv1R4cvUPvIDbo_3dnXJnvLf9FNY4RfA0B04bsLo4OQ3PEIIt7POG71P4cd0b7Q_9Nzs3
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3ra9RAEB_0CsUvxXejVaMIghCbfWXTj_VxtD6KSIv9FjL70IOSK73r_-9Msjk9WsWPSWbDMLOz89udxwK8JMhqGHoXLgZVaHosUEhbBIOoRfTBtX2W71F1cKI_nprTdODGtTBJgos3nFZFHPWLNVv3uY-7Kca4Sy6PKyo1b144kmRvwobWtMmbwMb-9Nv343Et5otlhpJIUxU8IsU1r_3JmmfqG_hfhzqvJk_-kQHWO6XpbdhKaDLfH9R_B26E7i5sfknx8nvw4rCLpPKhPDGfdfmYP5gviJ7YmC3uw8n0w_G7gyLdilA4o-SyUF60SqKT2u8pF8tgogoBnYi2tJbQmjd72novUFvZYl0Fi5EbCzotPAOQBzDp5l3YhpzAjpdIG4xYex0j2XIrfe2DRkl-zZkMylEijUstw_nmirNGpC7hV4SYwevVkPOhX8a_iN-ymFeE3Oq6fzG_-NEkyyFv7lGUypW-Rt1a3aJGgbKtjMeK0GsGO6OSmnH2NLQvJKRIyq8yeL76TJbD4ZC2C_NLoiHoSejQ1iqDh4NOV5woxV1sRJ2BXdP2GqvrX7rZz747d03LGi2TGbziefGbpb9K4dF_Uz6Dza_vp83nw6NPj-GW5Oya_jBoBybLi8vwhODREp8mG_gFMEAAkA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inflammation+in+multiple+sclerosis&rft.jtitle=Therapeutic+advances+in+neurological+disorders&rft.au=Haase%2C+Stefanie&rft.au=Linker%2C+Ralf+A&rft.date=2021&rft.issn=1756-2856&rft.volume=14&rft.spage=17562864211007687&rft_id=info:doi/10.1177%2F17562864211007687&rft_id=info%3Apmid%2F33948118&rft.externalDocID=33948118
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-2864&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-2864&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-2864&client=summon